Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | AKT1 | P31749 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | PTAFR | P25105 | 1/20 | 0.44 |
| ▸ | HTR1D | P28221 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35785 | 0.96 | SMN1; SMN2 (0.49) | THRBSMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL20401677 | 0.96 | SMN1; SMN2 (0.49) | THRBSMN1; SMN2LMNAAKT1ESR1 | |
| Phosphocholine SCHEMBL12979922 | 0.90 | SMN1; SMN2 (0.45) | THRBSMN1; SMN2LMNAAKT1ESR1 | |
| Phosphoric Acid SCHEMBL30511659 | 0.88 | THRB (0.53) | THRBSMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL18139544 | 0.88 | THRB (0.56) | THRBADRA1DPTAFRHTR1DHTR2C | |
| Lithium Ion SCHEMBL18140320 | 0.88 | THRB (0.56) | THRBADRA1DPTAFRHTR1DHTR2C | |
| Potassium Ion SCHEMBL18139687 | 0.88 | THRB (0.56) | THRBADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL18140774 | 0.88 | THRB (0.56) | THRBADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL18141475 | 0.88 | THRB (0.56) | THRBADRA1DPTAFRHTR1DHTR2C | |
| Lithium Ion SCHEMBL18139459 | 0.88 | THRB (0.56) | THRBADRA1DPTAFRHTR1DHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3896074-B1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | AIST (JP) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022235329-A1 | BRAIN-TARGETED ANTIBODY NANOPARTICLE FOR NEURODEGENERATIVE DISEASES THERAPY | UNIVERSITY OF SOUTH CAROLINA (US) | 2022-11-10 | — | — | WO | disclosed |
| CN-108885190-B | Biosensor and biochip | TDK株式会社 | 2022-06-24 | — | — | CN | disclosed |
| US-20220017648-A1 | Method, Kit, and Device for Preparing Glycan from Glycoprotein | SUMITOMO BAKELITE CO., LTD. (JP) | 2022-01-20 | — | — | US | disclosed |
| EP-3896074-A1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2021-10-20 | — | — | EP | disclosed |
| US-11136344-B2 | Purification agent for sugar chain or glycopeptide, and use thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2021-10-05 | — | — | US | disclosed |
| CN-113383003-A | Method, kit and apparatus for producing sugar chain from glycoprotein | 国立研究开发法人产业技术综合研究所 | 2021-09-10 | — | — | CN | disclosed |
| EP-3394622-B1 | REAGENT DILUENT | BIOMERIEUX SA (FR) | 2021-08-04 | — | — | EP | disclosed |
| EP-3650456-B1 | PURIFICATION AGENT FOR SUGAR CHAIN OR GLYCOPEPTIDE, AND USE THEREOF | SUMITOMO BAKELITE CO (JP) | 2021-07-07 | — | — | EP | disclosed |
| US-11009505-B2 | Reagent diluent | BIOMERIEUX (FR) | 2021-05-18 | — | — | US | disclosed |
| US-20090042190-A1 | Method of detecting gene | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 2009-02-12 | — | — | US | disclosed |
| US-7438860-B2 | Droplet discharging head and microarray manufacturing method | SEIKO EPSON CORPORATION (JP) | 2008-10-21 | — | — | US | disclosed |
| EP-1930422-A1 | METHOD FOR PRODUCING CDNA AND RNA CHAINS AND NUCLEOTIDE-IMMOBILIZED SUPPORT | Sumitomo Bakelite Company, Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1908848-A1 | METHOD FOR DETECTION OF GENE | Sumitomo Bakelite Company, Ltd. (JP) | 2008-04-09 | — | — | EP | disclosed |
| US-7323224-B2 | Liquid dispense method and microarray manufacturing method | SEIKO EPSON CORPORATION (JP) | 2008-01-29 | — | — | US | disclosed |
| US-7166476-B2 | Allowing an antibody or an antibody complex which reacts specifically to the antigenic substance and binds to the antigenic substance to give a selective agglutination of the insoluble carrier particles | KYOWA MEDEX CO., LTD. (JP) | 2007-01-23 | — | — | US | disclosed |
| US-20060177585-A1 | Liquid dispense method and microarray manufacturing method | KAZUHIKO ISHIHARA (JP) | 2006-08-10 | — | — | US | disclosed |
| US-20050008497-A1 | Droplet discharging head and microarray manufacturing method | SEIKO EPSON CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20030166302-A1 | Highly reproducible agglutination immunoassay method and reagents | FUJIREBIO INC. (JP) | 2003-09-04 | — | — | US | disclosed |
| EP-1314982-A1 | HIGHLY REPRODUCIBLE AGGLUTINATION IMMUNOASSAY METHOD AND REAGENTS | KYOWA MEDEX CO., LTD. (JP) | 2003-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11136344-B2 | Purification agent for sugar chain or glycopeptide, and use thereof | FUT5, MANBA, MGAM | THRB 711/4885SMN1; SMN2 3076/4885LMNA 1865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.